Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 9537 - Advisory Committee on Organ Transplantation - Authorized by Law


Committee NameAdvisory Committee on Organ TransplantationAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number9537
Original Establishment Date3/16/2000Committee StatusChartered
Actual Termination Date Committee URL
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*17
Current Charter Date8/31/2022Designated Fed Officer Position Title*Policy Advisor, Division of Transplantation, Healthcare Systems Bureau
Date Of Renewal Charter8/31/2024Designated Federal Officer PrefixMs.
Projected Termination Date Designated Federal Officer First Name*Shelley
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Grant
Establishment Authority*Authorized by LawDesignated Federal Officer Suffix
Specific Establishment Authority*42 U.S.C. 217aDesignated Federal Officer Phone*(301) 443-8036
Effective Date Of Authority*3/16/2000Designated Federal Officer Fax*301-594-6095
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*
Committee Type*Continuing
Committee Function*Non Scientific Program Advisory Board


Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The ACOT accomplishes its purpose by meeting in full session and establishing special topic workgroups related to organ transplantation.
How is membership balanced?*The ACOT membership includes individuals knowledgeable in such fields as deceased and living organ donation, health care public policy, transplantation medicine and surgery, critical care medicine and other medical specialties involved in the identification and referral of donors, non-physician transplant professions, nursing, epidemiology, immunology, law and bioethics, behavioral sciences, economics and statistics, as well as representatives of transplant candidates, transplant recipients, living organ donors, and family members of deceased and living organ donors. To the extent practicable, Committee members should represent the minority, gender and geographic diversity of transplant candidates, transplant recipients, organ donors and family members served by the Organ Procurement and Transplantation Network (OPTN).
How frequent & relevant are cmte mtgs?*The ACOT may meet up to three times in a fiscal year to advise the Secretary of HHS on matters related to organ transplantation.
Why advice can't be obtained elsewhere?*The ACOT members represent the various stakeholders that have an interest in solid organ transplantation. Members provide advice and recommendations to the Secretary of HHS based on their transplant-related scientific clinical, operational, and personal experience. This expertise is not available within HHS.
Why close or partially close meetings?N/A
Recommendation RemarksNo recommendations were produced in FY 2022, there was no Chair on ACOT for FY 2022, and no meetings were held in FY 2022. The max number of members changed from 31 to 17 to reflect the current ACOT charter.

Ex-officios Diane Coming, Sridhar Basavarju, and Nancy Bridges term end dates changed from 1/1/2022 to 9/30/2024 because they remain as ex-officios and their term continues on ACOT. Ex-officio Scott Brubaker's end date changed from 9/1/2022 to 9/30/2024 because they remain as an ex-officio and their term continues on ACOT.

All ex-officios' Appointment Type updated to reflect federal employee member as an ex-officio member of ACOT.


Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchNoAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionYesAction CommentN/A
Outcome Implement Laws/Reg RequirementsYesGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentN/ANumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentGrants Review CommentN/A
Number Of Recommendations*67Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentNo recommendations were produced in FY 2022.Access Agency WebsiteYes
% of Recs Fully Implemented*54.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentThese recommendations have been implemented to improve organ transplantation service delivery, access, and equity.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*46.00%Access PublicationsNo
% of Recs Partially Implemented CommentThe Program and the community are engaged in discussions about the implementation of all recommendations.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback Comment*No recommendations were produced in FY 2022. No meetings were held in FY 2022. The Secretary of HHS acknowledges receipt of any recommendations. The public can obtain information on agency feedback at the ACOT website: Description*The ACOT advises the Secretary of HHS on all aspects of organ donation, procurement, allocation, and transplantation, as well as other matters that the Secretary determines. One of its principal functions is to advise the Secretary on federal efforts to maximize the number of deceased donor organs made available for transplantation and to support the safety of living organ donation. The ACOT, at the request of the Secretary, reviews significant proposed OPTN policies submitted for the Secretary’s approval to recommend whether they should be made enforceable.
Hide Section - COSTS


Payments to Non-Federal Members*$0.00Est Payments to Non-Fed Members Next FY*$15,400.00
Payments to Federal Members*$0.00Est. Payments to Fed Members Next FY*$4,610.00
Payments to Federal Staff*$114,936.00Estimated Payments to Federal Staff*$181,168.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$1,000.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$0.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$5,000.00Est. Other Costs Next FY*$64,800.00
Total Costs$119,936.00Est. Total Next FY*$266,978.00
Date Cost Last Modified11/14/2022 1:45 PMEst. Fed Staff Support Next FY*0.95
Federal Staff Support (FTE)*0.62Est Cost RemarksOther costs include the HRSA FACA Meeting BPA. Costs are significantly higher than FY 2022 in anticipation of meetings. Only virtual meetings are projected for FY 2023 so no travel costs are included. FTE and estimated payments to federal staff is higher than the .62 listed in the current charter because after the charter was finalized it was proposed that another staff person provide administrative support in FY 2023.
Cost RemarksOther costs include the baseline cost for the HRSA FACA Meeting BPA even though no meetings of ACOT occurred in FY 2022.  
Hide Section - Interest Areas

Interest Areas



To View all the members, meetings and advisory reports for this committee please click here


No Documents Found



Data from Previous Years

ActionCommittee System IDCommittee NameFiscal Year
 COM-040383Advisory Committee on Organ Transplantation2021
 COM-038660Advisory Committee on Organ Transplantation2020
 COM-036530Advisory Committee on Organ Transplantation2019
 COM-034743Advisory Committee on Organ Transplantation2018
 COM-001972Advisory Committee on Organ Transplantation2017
 COM-002261Advisory Committee on Organ Transplantation2016
 COM-004171Advisory Committee on Organ Transplantation2015
 COM-004787Advisory Committee on Organ Transplantation2014
 COM-006286Advisory Committee on Organ Transplantation2013
 COM-006585Advisory Committee on Organ Transplantation2012
 COM-008233Advisory Committee on Organ Transplantation2011
 COM-008829Advisory Committee on Organ Transplantation2010
 COM-010401Advisory Committee on Organ Transplantation2009
 COM-010695Advisory Committee on Organ Transplantation2008
 COM-012230Advisory Committee on Organ Transplantation2007
 COM-012813Advisory Committee on Organ Transplantation2006
 COM-013993Advisory Committee on Organ Transplantation2005
 COM-014608Advisory Committee on Organ Transplantation2004
 COM-015866Advisory Committee on Organ Transplantation2003
 COM-016548Advisory Committee on Organ Transplantation2002
 COM-017890Advisory Committee on Organ Transplantation2001